Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum

International Journal for Parasitology

Volumn 37, Issue 2, 2007, Pages 183-190

  Esposito, Marco ^a   Müller, Norbert ^a   Hemphill, Andrew ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

3D QSAR; Intacellular parasite; Neospora caninum; Nitazoxanide; SOMFA; Thiazolides

Indexed keywords

NITAZOXANIDE; RM 4801; RM 4802; RM 4803; RM 4804; RM 4805; RM 4806; RM 4807; RM 4809; RM 4819; RM 4820; RM 4821; RM 4822; RM 4826; RM 4827; RM 4831; RM 4832; RM 4833; RM 4835; RM 4836; RM 4837; RM 4839; RM 4840; RM 4841; RM 4844; RM 4845; RM 4846; RM 4847; THIAZOLE DERIVATIVE; TIZOXANIDE; UNCLASSIFIED DRUG;

DRUG; DRUG DEVELOPMENT; ENDOPARASITE; PARASITE CONTROL; POLYMERASE CHAIN REACTION; PROTOZOAN; REAL TIME; THREE-DIMENSIONAL MODELING;

ANALYTIC METHOD; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; APICOMPLEXAN LIFE CYCLE STAGE; ARTICLE; ATOM; CELL MATURATION; CHEMICAL BOND; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRICITY; FOOD; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR MODEL; NEOSPORA CANINUM; NONHUMAN; PREDICTION; PROTOZOON; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; TACHYZOITE; VALIDATION PROCESS;

ANIMALS; ANTIPROTOZOAL AGENTS; CATTLE; DOGS; DRUG DESIGN; NEOSPORA; POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; THIAZOLIDINES; TISSUE CULTURE TECHNIQUES;

ANIMALIA; ENTEROBACTERIACEAE; NEOSPORA CANINUM; PROTOZOA; VERMES;

EID: 33846098250     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2006.10.009     Document Type: Article

References (18)

1. Dubey J.P., Barr B.C., Barta J.R., Bjerkas I., Bjorkman C., Blagburn B.D., Bowman D.D., Buxton D., Ellis J.T., Gottstein B., Hemphill A., Hill D.E., Howe D.K., Jenkins M.C., Kobayashi Y., Koudela B., Marsh A.E., Mattsson J.G., McAllister M.M., Modry D., Omata Y., Sibley L.D., Speer C.A., Trees A.J., Uggla A., Upton S.J., Williams D.J.L., and Lindsay D.L. Redescription of Neospora caninum and its differentiation from related coccidia. Int. J. Parasitol. 32 (2002) 929-946
2. Esposito M., Stettler R., Moores S.L., Pidathala C., Muller N., Stachulskii A., Berry N.G., Rossignol J.F., and Hemphill A. In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob. Agents Chemother. 49 (2005) 3715-3723
3. Esposito M., Moores S.L., and Hemphill A. Nitazoxanide and thiazolides, a novel class of broad-spectrum anti-parasitic drugs. Res. Adv. Antimicrob. Agents Chemother. 6 (2006) 1-11
4. Fox L.M., and Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 40 (2005) 1173-1180
5. Hemphill A., and Gottstein B. A European perspective on Neospora caninum. Int. J. Parasitol. 30 (2000) 877-924
6. Hemphill A., Vonlaufen N., and Naguleswaran A. Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology. 133 (2006) 261-278
7. Hemphill A., Mueller J., and Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Exp. Op. Pharmacother 7 (2006) 953-964
8. Hemphill A. Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein. Infect. Immun. 64 (1996) 4279-4287
9. Innes E.A., Wright S., Bartley P., Maley S., Macaldowie C., Esteban Redondo I., and Buxton D. The host-parasite relationship in bovine neosporosis. Vet. Immunol. Immunopathol. 108 (2005) 29-36
10. McClure S., and Palma K. Treatment of equine protozoal myeloencephalitis with Nitazoxanide. J. Eq. Vet. Sci. 19 (1999) 639-641
11. Müller N., Zimmerman V., Hentrich B., and Gottstein B. Diagnosis of Neospora caninum and Toxoplasma gondiiinfection by PCR and DNA hybridization immunoassay. J. Clin. Microbiol. 34 (1996) 2850-2852
12. Müller J., Ruhle G., Muller N., Rossignol J.F., and Hemphill A. In vitro effects of thiazolides on Giardia lamblia WB Clone C6 cultured axenically and in coculture with Caco2 Cells. Antimicrob. Agents. Chemother. 50 (2006) 162-170
13. Naguleswaran A., Müller N., and Hemphill A. Neospora caninum and Toxoplasma gondii: A novel adhesion/invasion assay reveals distinct differences in tacyzoite-host cell interactions. Exp. Parasitol. 104 (2003) 149-158
14. Pankuch G.A., and Appelbaum P.C. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species. Antimicrob. Agents Chemother. 50 (2006) 1112-1117
15. Robinson D.D., Winn P.J., Lyne P.D., and Richards W.G. Self-organizing molecular field analysis (SOMFA): a tool for structure-activity studies. J. Med. Chem. 42 (1999) 573-583
16. Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob. Agents Chemother. 43 (1999) 1533-1541
17. Schmidt M.W., Baldridge K.K., Boatz J.A., Elbert S.T., Gordon M.S., Jensen J.J., Koseki S., Matsunaga N., Nguyen K.A., Su S., Windus T.L., Dupuis M., and Montgomery J.A. GAMESS. J. Comput. Chem. 14 (1993) 1347-1363
18. Sisson G., Goodwin A., Raudonikiene A., Hughes N.J., Mukhopadhyay A.K., Berg D.A., and Hoffman P.S. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 46 (2002) 2116-2123